Michaela Ann Dinan, PhD

Adjunct Professor in the Department of Population Health Sciences
Assistant Professor in Medicine
Membership in the Duke Clinical Research Institute
Campus mail 60 College St, PO Box 208034, New Haven, CT 06520
Phone (203) 785-7214
Email address michaela.dinan@duke.edu

Dr. Dinan is a health services researcher by training and she specializes in using econometric and epidemiologic methodologies to analyze complex datasets. Specifically, Dr. Dinan's research involves issues related to advances in cancer care technologies, such as emerging treatments and diagnostics, and how these advances in technologies impact different cancer outcomes and experiences such as access, quality of care, cost of care, and health disparities.

Dr. Dinan has led studies funded by the National Institutes of Health, the American Cancer Society, and the Agency for Healthcare Research and Quality. She is currently leading an NCI-funded R01 study examining multi-level factors that contribute to disparities in access and adherence to oral anticancer agents for patients with kidney cancer. Dr. Dinan is also leading a study funded by the ACS to develop and validate risk prediction algorithms to inform efficient and high-quality care for long-term cancer survivors.

Areas of expertise: Health Economics, Health Policy, and Health Services Research

Education and Training

  • Ph.D., University of North Carolina - Chapel Hill, 2011
  • B.S., University of Virginia, 2003

Publications

Pritchard, Jessica E., Lauren E. Wilson, Samuel M. Miller, Melissa A. Greiner, Harvey Jay Cohen, Deborah R. Kaye, Tian Zhang, and Michaela A. Dinan. “Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma.” J Am Geriatr Soc, May 2, 2022. https://doi.org/10.1111/jgs.17826.

PMID
35499667
Full Text

Check, Devon K., Renee A. V. Avecilla, Coleman Mills, Michaela A. Dinan, Arif H. Kamal, Beverly Murphy, Salma Rezk, Aaron Winn, and Kevin C. Oeffinger. “Opioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies.” J Pain Symptom Manage 63, no. 4 (April 2022): e397–417. https://doi.org/10.1016/j.jpainsymman.2021.10.015.

PMID
34748896
Full Text

Leapman, Michael S., Michaela Dinan, Saamir Pasha, Jessica Long, Samuel L. Washington, Xiaomei Ma, and Cary P. Gross. “Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.” Jama Oncol, March 3, 2022. https://doi.org/10.1001/jamaoncol.2021.8116.

PMID
35238879
Full Text

Kaye, Deborah R., Lauren E. Wilson, Melissa A. Greiner, Lisa P. Spees, Jessica E. Pritchard, Tian Zhang, Craig E. Pollack, et al. “Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma.” J Geriatr Oncol, February 3, 2022. https://doi.org/10.1016/j.jgo.2022.01.008.

PMID
35125336
Full Text

Miller, Samuel M., Lauren E. Wilson, Melissa A. Greiner, Jessica E. Pritchard, Tian Zhang, Deborah R. Kaye, Harvey Jay Cohen, Robert D. Becher, Linda L. Maerz, and Michaela A. Dinan. “Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma.” J Geriatr Oncol, January 4, 2022. https://doi.org/10.1016/j.jgo.2021.12.012.

PMID
34996724
Full Text

Wheeler, Stephanie B., Lisa P. Spees, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner, Deborah R. Kaye, et al. “Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell Carcinoma.” Jco Oncol Pract 17, no. 12 (December 2021): e1895–1904. https://doi.org/10.1200/OP.20.01082.

PMID
34138665
Full Text

Zullig, Leah L., Mohammad Shahsahebi, Benjamin Neely, Terry Hyslop, Renee A. V. Avecilla, Brittany M. Griffin, Kacey Clayton-Stiglbauer, et al. “Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trial.” Bmc Fam Pract 22, no. 1 (November 18, 2021): 234. https://doi.org/10.1186/s12875-021-01569-8.

PMID
34794388
Full Text

Check, Devon K., Christopher D. Baggett, KyungSu Kim, Andrew W. Roberts, Megan C. Roberts, Timothy Robinson, Kevin C. Oeffinger, and Michaela A. Dinan. “Predictors of Chronic Opioid Use: A Population-Level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims.” J Natl Cancer Inst 113, no. 11 (November 2, 2021): 1581–89. https://doi.org/10.1093/jnci/djab082.

PMID
33881543
Full Text

Leapman, Michael S., Rong Wang, Henry S. Park, James B. Yu, Preston C. Sprenkle, Michaela A. Dinan, Xiaomei Ma, and Cary P. Gross. “Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management.” Jama Netw Open 4, no. 10 (October 1, 2021): e2128646. https://doi.org/10.1001/jamanetworkopen.2021.28646.

PMID
34623406
Full Text

Robinson, Timothy J., Lauren E. Wilson, P Kelly Marcom, Melissa Troester, Charles F. Lynch, Brenda Y. Hernandez, Edgardo Parrilla, Heather Ann Brauer, and Michaela A. Dinan. “Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.” Jama Netw Open 4, no. 10 (October 1, 2021): e2131020. https://doi.org/10.1001/jamanetworkopen.2021.31020.

PMID
34714340
Full Text

Pages